← Back to all articles
PharmacologyPubMed VerifiedOpen Access

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Chaves C, Dos Santos RG, Dursun SM, Tusconi M, Carta MG, Brietzke E, Hallak JEC

Frontiers in Psychiatry (2024)

Review
Abstract

Reviews DMT's unique pharmacological features distinguishing it from other classical psychedelics: endogenous production, sigma-1 receptor activity, short duration of action, and neuroplasticity promotion. Discusses implications for therapeutic development including oral (ayahuasca), IV, and intranasal formulations.

Citations5
Study TypeReview
DMTunique featurestherapeutic potentialsigma-1endogenousformulations
DOI: 10.3389/fpsyt.2024.1485337View on PubMed

Related Articles

Pharmacology

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Aicher HD, Mueller MJ et al.

Frontiers in Psychiatry, 2024
Pharmacology

The psychedelic N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator

Fontanilla D, Johannessen M et al.

Science, 2009
Pharmacology

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Salles G, de Carvalho Alves I et al.

Archives of Toxicology, 2025
Pharmacology

Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans

Wittayakarn N, Tan YM et al.

Toxicological Sciences, 2025